Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Campbell

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The British Journal of Surgery|September 1, 1985
Patterns of flap recurrence following mastectomyP F Blacklay, F C Campbell, C P Hinton, et al.
British Journal of Cancer|March 1, 1982
A prognostic index in primary breast cancerJ L Haybittle, R W Blamey, C W Elston, et al.
Clinical Oncology|June 1, 1984
The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot studyF C Campbell, D A Morgan, H M Bishop, et al.
The International Journal of Biological Markers|July 13, 2002
Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection--relationship to platelet countG M Spence, A N J Graham, K Mulholland, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
Clinical Oncology|December 1, 1984
The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breastM R Williams, A C Perkins, F C Campbell, et al.
Clinical and Experimental Immunology|March 3, 2011
Enhanced lymphocyte interferon (IFN)-γ responses in a PTEN mutation-negative Cowden disease kindredR Stevenson, A Fatehullah, I Jagan, et al.
Pharmacogenetics|November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerD E Bamber, A A Fryer, R C Strange, et al.
Oncogene|September 17, 2008
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontinV V Kurisetty, P G Johnston, N Johnston, et al.
British Journal of Cancer|June 2, 2005
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colonE T Donnelly, H Bardwell, G A Thomas, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The British Journal of Surgery|September 1, 1985
Patterns of flap recurrence following mastectomyP F Blacklay, F C Campbell, C P Hinton, et al.
British Journal of Cancer|March 1, 1982
A prognostic index in primary breast cancerJ L Haybittle, R W Blamey, C W Elston, et al.
Clinical Oncology|June 1, 1984
The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot studyF C Campbell, D A Morgan, H M Bishop, et al.
The International Journal of Biological Markers|July 13, 2002
Vascular endothelial growth factor levels in serum and plasma following esophageal cancer resection--relationship to platelet countG M Spence, A N J Graham, K Mulholland, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
Clinical Oncology|December 1, 1984
The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breastM R Williams, A C Perkins, F C Campbell, et al.
Clinical and Experimental Immunology|March 3, 2011
Enhanced lymphocyte interferon (IFN)-γ responses in a PTEN mutation-negative Cowden disease kindredR Stevenson, A Fatehullah, I Jagan, et al.
Pharmacogenetics|November 3, 2001
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancerD E Bamber, A A Fryer, R C Strange, et al.
Oncogene|September 17, 2008
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontinV V Kurisetty, P G Johnston, N Johnston, et al.
British Journal of Cancer|June 2, 2005
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colonE T Donnelly, H Bardwell, G A Thomas, et al.
Pageof 7